A meta-analysis of spinal surgical site infection and vancomycin powder

Journal of Neurosurgery: Spine

Volumn 21, Issue 6, 2014, Pages 974-983

  Khan, Nickalus R ^a   Thompson, Clinton J ^b   Decuypere, Michael ^a   Angotti, Jonathan M ^a   Kalobwe, Erick ^c   Muhlbauer, Michael S ^a,d   Camillo, Francis X ^a,e   Klimo, Paul ^a,d  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c LeMoyne Owen College   (United States)

^d SEMMES MURPHEY NEUROLOGIC AND SPINE INSTITUTE   (United States)

^e Campbell Clinic Orthopaedics   (United States)

Author keywords

Meta analysis; Spine surgery; Surgical site infection; Vancomycin powder

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT; POWDER;

ARTICLE; COHORT ANALYSIS; DATA BASE; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; META ANALYSIS; OUTCOME ASSESSMENT; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK FACTOR; RISK REDUCTION; SPINE SURGERY; SURGICAL INFECTION; ADMINISTRATION AND DOSAGE; ANTIBIOTIC PROPHYLAXIS; POWDER; PROCEDURES; SPINAL DISEASES; SURGICAL WOUND INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; HUMANS; POWDERS; SPINAL DISEASES; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 84925223129     PISSN: 15475654     EISSN: 15475646     Source Type: Journal    
DOI: 10.3171/2014.8.SPINE1445     Document Type: Article

References (54)

1. Anderson DJ, Kaye KS, Classen D, Arias KM, Podgorny K, Burstin H, et al: Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 29(Suppl 1):S51-S61, 2008
2. Caroom C, Tullar JM, Benton EG Jr, Jones JR, Chaput CD: Intrawound vancomycin powder reduces surgical site infections in posterior cervical fusion. Spine (Phila Pa 1976) 38:1183-1187, 2013
3. Chi J: Powder time? Reducing spinal postoperative infections with intrawound application of antibiotic powder. Neurosurgery 70:N12-N13, 2012
4. Collins I, Wilson-MacDonald J, Chami G, Burgoyne W, Vineyakam P, Berendt T, et al: The diagnosis and management of infection following instrumented spinal fusion. Eur Spine J 17:445-450, 2008
5. Crowther M, Lim W, Crowther MA: Systematic review and meta-analysis methodology. Blood 116:3140-3146, 2010
6. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
7. Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634, 1997
8. Emohare O, Ledonio CG, Hill BW, Davis RA, Polly DW Jr, Kang MM: Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. Spine J [epub ahead of print], 2014
9. Fang A, Hu SS, Endres N, Bradford DS: Risk factors for infection after spinal surgery. Spine (Phila Pa 1976) 30:1460-1465, 2005
10. Gans I, Dormans JP, Spiegel DA, Flynn JM, Sankar WN, Campbell RM, et al: Adjunctive vancomycin powder in pediatric spine surgery is safe. Spine (Phila Pa 1976) 38:1703-1707, 2013
11. Ghobrial GM, Thakkar V, Andrews E, Lang M, Chi tale A, Oppenlander ME, et al: Intraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine (Phila Pa 1976) 39:550-555, 2014
12. Glotzbecker MP, Riedel MD, Vitale MG, Matsumoto H, Roye DP, Erickson M, et al: What's the evidence? Systematic literature review of risk factors and preventive strategies for surgical site infection following pediatric spine surgery. J Pediatr Orthop 33:479-487, 2013
13. Glotzbecker MP, Vitale MG, Shea KG, Flynn JM, POSNA committee on the Quality, Safety, Value Initiative: Surgeon practices regarding infection prevention for pediatric spinal surgery. J Pediatr Orthop 33:694-699, 2013
14. Godil SS, Parker SL, O'Neill KR, Devin CJ, McGirt MJ: Com - parative effectiveness and cost-benefit analysis of local ap plication of vancomycin powder in posterior spinal fusion for spine trauma. Clinical article. J Neurosurg Spine 19:331-335, 2013
15. Heller A, McIff TE, Lai SM, Burton DC: Intrawound vancomycin powder decreases staphylococcal surgical site infections following posterior instrumented spinal arthrodesis. J Spinal Disord Tech [epub ahead of print], 2013
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ 327:557-560, 2003
17. Hill BW, Emohare O, Song B, Davis R, Kang MM: The use of vancomycin powder reduces surgical reoperation in posterior instrumented and noninstrumented spinal surgery. Acta Neurochir (Wien) 156:749-754, 2014
18. Ho C, Skaggs DL, Weiss JM, Tolo VT Management of infec - tion after instrumented posterior spine fusion in pediatric sco liosis. Spine (Phila Pa 1976) 32:2739-2744, 2007
19. Howick J, Chalmers I, Glasziou P, Greenhalgh T, Heneghan C, Liberati A, et al: Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. (http://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-21.pdf) [Accessed August 18, 2014]
20. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al: Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1-12, 1996
21. Kanj WW, Flynn JM, Spiegel DA, Dormans JP, Baldwin KD: Vancomycin prophylaxis of surgical site infection in clean orthopedic surgery. Orthopedics 36:138-146, 2013
22. Kirby JP, Mazuski JE Prevention of surgical site infection. Surg Clin North Am 89:365-389, viii, 2009
23. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ: The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20:725-730, 1999
24. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, et al: Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771, 2007
25. Klimo P Jr, Thompson CJ, Ragel BT, Boop FA: Antibioticimpregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis. Clinical article. J Neurosurg Pediatr 8:600-612, 2011
26. Lazar HL, Barlam T, Cabral H: The effect of topical vancomycin applied to sternotomy incisions on postoperative serum vancomycin levels. J Card Surg 26:461-465, 2011
27. Lewis SS, Moehring RW, Chen LF, Sexton DJ, Anderson DJ: It's time to change our focus: surgical site infections (SSI) account for the greatest proportion of hospital-acquired infections (HAIs). IDWeek. (Abstract) (https://idsa.confex.com/idsa/2013/webprogram/Paper40641.html) [Accessed August 14, 2014]
28. Mariappan R, Manninen P, Massicotte EM, Bhatia A: Circulatory collapse after topical application of vancomycin powder during spine surgery. Case report. J Neurosurg Spine 19:381-383, 2013
29. Martin JR, Adogwa O, Brown CR, Bagley CA, Richardson WJ, Lad SP, et al: Experience with intrawound vancomycin powder for spinal deformity surgery. Spine (Phila Pa 1976) 39:177-184, 2014
30. Mohammed S, Pisimisis GT, Daram SP, Bechara CF, Barshes NR, Lin PH, et al: Impact of intraoperative administration of local vancomycin on inguinal wound complications. J Vasc Surg 57:1079-1083, 2013
31. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group: Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 6:e1000097, 2009
32. Molinari RW, Khera OA, Molinari WJ III: Prophylactic intraoperative powdered vancomycin and postoperative deep spinal wound infection: 1, 512 consecutive surgical cases over a 6-year period. Eur Spine J 21(Suppl 4):S476-S482, 2012
33. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, et al: National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 45:1132-1140, 2007
34. Olsen MA, Mayfield J, Lauryssen C, Polish LB, Jones M, Vest J, et al: Risk factors for surgical site infection in spinal surgery. J Neurosurg 98(2 Suppl):149-155, 2003
35. Olsen MA, Nepple JJ, Riew KD, Lenke LG, Bridwell KH, Mayfield J, et al: Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am 90:62-69, 2008
36. O'Neill KR, Smith JG, Abtahi AM, Archer KR, Spengler DM, McGirt MJ, et al: Reduced surgical site infections in patients undergoing posterior spinal stabilization of traumatic injuries using vancomycin powder. Spine J 11:641-646, 2011
37. Pahys JM, Pahys JR, Cho SK, Kang MM, Zebala LP, Hawasli AH, et al: Methods to decrease postoperative infections following posterior cervical spine surgery. J Bone Joint Surg Am 95:549-554, 2013
38. Pull ter Gunne AF, Hosman AJ, Cohen DB, Schuetz M, Habil D, van Laarhoven CJ, et al: A methodological systematic review on surgical site infections following spinal surgery: part 1: risk factors. Spine (Phila Pa 1976) 37:2017-2033, 2012
39. Rechtine GR, Bono PL, Cahill D, Bolesta MJ, Chrin AM: Postoperative wound infection after instrumentation of thoracic and lumbar fractures. J Orthop Trauma 15:566-569, 2001
40. Savage JW, Anderson PA: An update on modifiable factors to reduce the risk of surgical site infections. Spine J 13:1017-1029, 2013
41. Schimmel JJ, Horsting PP, de Kleuver M, Wonders G, van Limbeek J: Risk factors for deep surgical site infections after spinal fusion. Eur Spine J 19:1711-1719, 2010
42. Schwarzkopf R, Chung C, Park JJ, Walsh M, Spivak JM, Steiger D: Effects of perioperative blood product use on surgical site infection following thoracic and lumbar spinal surgery. Spine (Phila Pa 1976) 35:340-346, 2010
43. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al: Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10, 2007
44. Sterne JA, Egger M: Funnel plots for detecting bias in metaanalysis: guidelines on choice of axis. J Clin Epidemiol 54:1046-1055, 2001
45. Sterne JA, Egger M, Smith GD: Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ 323:101-105, 2001
46. Strom RG, Pacione D, Kalhorn SP, Frempong-Boadu AK: Decreased risk of wound infection after posterior cervical fusion with routine local application of vancomycin powder. Spine (Phila Pa 1976) [epub ahead of print], 2013
47. Strom RG, Pacione D, Kalhorn SP, Frempong-Boadu AK: Lumbar laminectomy and fusion with routine local application of vancomycin powder: decreased infection rate in instrumented and non-instrumented cases. Clin Neurol Neurosurg 115:1766-1769, 2013
48. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al: Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008-2012, 2000
49. Sweet FA, Roh M, Sliva C: Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine (Phila Pa 1976) 36:2084-2088, 2011
50. Tubaki VR, Rajasekaran S, Shetty AP: Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine (Phila Pa 1976) 38:2149-2155, 2013
51. Vander Salm TJ, Okike ON, Pasque MK, Pezzella AT, Lew R Traina V, et al: Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 98:618-622, 1989
52. Vitale MG, Riedel MD, Glotzbecker MP, Matsumoto H, Roye DP, Akbarnia BA, et al: Building consensus: development of a best practice guideline (BPG) for surgical site infection (SSI) prevention in high-risk pediatric spine surgery. J Pediatr Orthop 33:471-478, 2013
53. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. (http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp) [Accessed August 14, 2014]
54. Xing D, Ma JX, Ma XL, Song DH, Wang J, Chen Y, et al: A methodological, systematic review of evidence-based independent risk factors for surgical site infections after spinal surgery. Eur Spine J 22:605-615, 2013